New evidence-based guidelines on motor neurone disease will have a ‘hugely significant’ impact on patient care, according to a national charity.
The guidance, published this week by the National Institute for Health and Care Excellence (NICE) and developed by the National Clinical Guideline Centre (NCGC), has been welcomed by the Motor Neurone Disease Association (MNDA).
Sally Light, Chief Executive of the MNDA, commented on the news: ‘The MND Association strongly welcomes the publication of the NICE guideline on MND. This long awaited guideline has come about after more than four years of campaigning by the Association and our supporters.’
She went on: ‘It is a hugely significant document that sets out in detail what good care looks like and how it should be delivered. It will shape future care and have a huge influence over the quality of life for people living with MND and their families and carers.’
The guideline aims to improve and standardise care for peopl...